These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22724226)

  • 1. [COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].
    Nohara R
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():341-4. PubMed ID: 22724226
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects).
    Takayama T; Hiro T; Yamagishi M; Daida H; Saito S; Yamaguchi T; Matsuzaki M
    Circ J; 2007 Feb; 71(2):271-5. PubMed ID: 17251680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Kaneda regarding article, "Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden".
    Kaneda H
    Circulation; 2008 Nov; 118(22):e706; author reply e708-9. PubMed ID: 19029473
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Sutton et al regarding article, "Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden".
    Sutton BS; Blumenthal RS; Kapur NK
    Circulation; 2008 Nov; 118(22):e707; author reply e708-9. PubMed ID: 19029474
    [No Abstract]   [Full Text] [Related]  

  • 6. Cosmic effect of rosuvastatin in COSMOS.
    Adachi T; Ohsuzu F
    Circ J; 2009 Nov; 73(11):2015-6. PubMed ID: 19851029
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Takayama T; Hiro T; Yamagishi M; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Circ J; 2009 Nov; 73(11):2110-7. PubMed ID: 19801853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Daida H; Takayama T; Hiro T; Yamagishi M; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Diabetol; 2012 Jul; 11():87. PubMed ID: 22831708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg].
    Scheen AJ
    Rev Med Liege; 2006 Apr; 61(4):267-72. PubMed ID: 16789616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors underlying regression of coronary atheroma with potent statin therapy.
    Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
    Samady H; McDaniel MC
    JACC Cardiovasc Interv; 2009 Jul; 2(7):697-700. PubMed ID: 19628195
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
    Hong MK; Park DW; Lee CW; Lee SW; Kim YH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2009 Jul; 2(7):679-88. PubMed ID: 19628193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.
    Shin ES; Garcia-Garcia HM; Okamura T; Serruys PW
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1643-52. PubMed ID: 22179944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not.
    Mintz GS
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):378-9. PubMed ID: 24448226
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose statins and atherosclerosis regression.
    Rozenman Y
    JAMA; 2006 Oct; 296(15):1836; author reply 1837. PubMed ID: 17047207
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose statins and atherosclerosis regression.
    von Birgelen C; Hartmann M
    JAMA; 2006 Oct; 296(15):1837; author reply 1837. PubMed ID: 17047210
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2010 Nov; 106(9):1241-7. PubMed ID: 21029819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound].
    Yang HB; Zhao XY; Zhao YT; Zhang JY; Li L
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1550-2. PubMed ID: 22944060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.